JSPRJasper Therapeutics Inc. Common Stock
0.7160USD-4.10%Mkt Cap: 23.82M $P/E: —3d ago
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a …
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap23.82M $
Enterprise Value8.73M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-75.80M $
Revenue/Share—
Last Price0.7160 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees22
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.27
PEG—
EV/EBITDA-0.13
EV/Revenue—
P/S—
P/B5.71
EPS (TTM)-0.86
EPS (Forward)-2.56
52W Range
0.315114% of range3.130
52W High3.130 USD
52W Low0.3151 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-1826.09%
ROA-211.86%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-77.16M $
CapEx (TTM)7.00K $
FCF Margin—
FCF Yield-176.81%
Net Debt-13.39M $
Net Debt/EBITDA0.19
Balance Sheet
Debt/Equity0.30
Current Ratio2.26
Quick Ratio1.57
Book Value/Sh0.1210 USD
Cash/Share0.5050 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJan 4, 2024
Analyst Consensus
Rating2.3 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)7.375 USD
Upside (mean)+930.0%
Target Range1.500 USD – 20.00 USD
$1.500+930.0% to mean$20.00
# Analysts4
Ownership
Shares Out.33.27M
Float23.31M
Insiders2.56%
Institutions43.12%
Short Interest
Short Ratio1.5d
Short % Float13.20%
Short % Out.12.96%
Shares Short4.31M
Short (prev mo.)1.70M
Technical
SMA 500.6190 (+15.7%)
SMA 2001.143 (-37.4%)
Beta3.03
S&P 52W Chg18.16%
Avg Vol (30d)1.81M
Avg Vol (10d)1.04M
Technical Indicators
RSI (14)49.9
MACD0.0403
MACD Signal0.0411
MACD Hist.-0.0007
BB Upper0.8984 USD
BB Middle0.7179 USD
BB Lower0.5374 USD
BB Width50.28%
ATR (14)0.1064 USD
Vol Ratio (20d)1.22x